
Nicopure Sues FDA Over Deeming E-Cigarette Regulations
Update (October 2026): This is a May 2016 news post, kept as dated news. Nicopure lost. The federal district court in Washington, D.C. ruled for FDA in July 2017, and on December 10, 2019, the D.C. Circuit affirmed that ruling, upholding the deeming rule and rejecting Nicopure's First Amendment claims.
The deeming rule took effect on August 8, 2016, and e-cigarettes now need FDA marketing authorization to be sold legally. In the U.S., you must be 21 or older to buy them.
It didn’t take long, but the first lawsuit aiming to stop the FDA’s deeming regulations on e-cigarettes is on the books. Tampa, Florida-based e-juice manufacturer Nicopure filed suit against the agency last week, claiming the regulations violate federal law as well as the First Amendment.
Nicopure produces several juice lines, including the popular Halo e-juice brand. The company says that as written, the potential regulations place far stricter limits on electronic cigarettes than traditional tobacco products under the Tobacco Control Act.
“Through one voice, Nicopure Labs has taken a stand to ensure the voices of all vapers are heard and that vapers are treated fairly and not with a single stroke of a broad brush by the FDA,” CEO and co-founder Jeff Stamler said in a statement.
More About the Lawsuit
The suit was filed Tuesday in the U.S. District Court for the District of Columbia, which is the court that handles litigation against government agencies. It was the first suit filed by a company in the industry and, as far as we could tell at the time, the only one trying to stop the regulations from taking effect.
Nicopure said it supports “reasonable regulation” of the industry, as did other e-juice makers, device manufacturers and store owners. Their focus was mostly on keeping low-quality e-liquids off the market.
“The government’s role is not to regulate for the sake of regulation; regulation must be based on sound science and robust procedure, and it must accomplish certain public health goals,” Nicopure legal counsel Patricia Kovacevic argues.
Nicopure argued that this wasn't happening in the nearly 500-page document.
Critics at the time said that, rather than focusing on e-liquid quality, the rule would effectively ban an estimated 95 percent of all e-cigarette devices on the market.
They also argued that the premarket applications now required would be so costly that mainly large tobacco companies could afford them.
Violations in FDA Regulations
Specifically, Nicopure contends that the looming regulations violate the Administrative Procedure Act. This 1946 law guides how federal agencies write new regulations, including making the process public and allowing citizens to comment.
The First Amendment claims were a little harder to decipher at first. The First Amendment states that
Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the government for a redress of grievances.
The free speech claims centered on the company's own rights. Nicopure objected to rules that bar companies from claiming a product is less harmful without FDA approval, and to the ban on giving away free samples.
“FDA’s rule does not protect the consumer from low quality products; instead, it places a disproportionate and unjustified regulatory burden on compliant companies such as ourselves, who are determined to drive the industry to the highest standards of quality and innovation,” CTO Jason del Giudice said.
The courts didn't agree. The D.C. Circuit held that FDA can require proof before e-cigarettes are marketed as safer, and that nothing about the ban on free e-cigarette samples runs afoul of the First Amendment.
Here is an overview directly from Nicopure:
Sources
- Nicopure Labs, LLC v. FDA, No. 17-5196 (D.C. Cir. Dec. 10, 2019), U.S. Court of Appeals for the D.C. Circuit
- Nicopure v. FDA case history, Public Health Law Center
- FDA's Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products, U.S. Food and Drug Administration


